RxSight, Inc.
RXST- Exchange
- Nasdaq
- Industry
- Ophthalmic Goods
- SEC CIK
- 0001111485
In the last 90 days, RxSight, Inc. insiders filed 0 open-market purchases and 4 sales; 151 institutions reported holding it in 13F filings for Q2 2026, worth $199.8M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in RxSight, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 174
- −14 vs. Q1 2025
- Shares held
- 37.0M
- +1.24M (+3.5%) vs. Q1 2025
- Total value
- $481.2M
- −$422.3M (−46.7%) vs. Q1 2025
- New holders
- 36
- 74 more added
- Sold out
- 50
- 39 more reduced
4 institutions that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RXST on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 151 | $199.8M |
| Q1 2026 | 164 | $235.2M |
| Q4 2025 | 164 | $381.8M |
| Q3 2025 | 160 | $298.8M |
| Q2 2025 | 174 | $481.2M |
| Q1 2025 | 192 | $924.1M |
| Q4 2024 | 212 | $1.21B |
| Q3 2024 | 214 | $1.68B |
| Q2 2024 | 228 | $1.98B |
| Q1 2024 | 197 | $1.58B |
| Q4 2023 | 169 | $1.17B |
| Q3 2023 | 128 | $718.1M |
| Q2 2023 | 115 | $637.0M |
| Q1 2023 | 74 | $264.4M |
| Q4 2022 | 58 | $121.6M |
| Q3 2022 | 53 | $109.3M |
| Q2 2022 | 49 | $131.0M |
| Q1 2022 | 45 | $108.3M |
| Q4 2021 | 40 | $75.0M |
| Q3 2021 | 39 | $100.3M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding RxSight, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Oppenheimer Asset Management Inc. | 0 | $0 | 0.00% | −8,693−100.0% | Sold out |
| Summit Global Investments | 0 | $0 | 0.00% | −8,393−100.0% | Sold out |
| Cim, LLC | 0 | $0 | 0.00% | −8,203−100.0% | Sold out |
| CIBC World Markets Corp | 0 | $0 | 0.00% | −8,185−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −7,984−100.0% | Sold out |
| Resona Asset Management Co.,Ltd. | 0 | $0 | 0.00% | −5,823−100.0% | Sold out |
| KBC Group NV | 0 | $0 | 0.00% | −2,107−100.0% | Sold out |
| Aster Capital Management (DIFC) Ltd | 0 | $0 | 0.00% | −1,859−100.0% | Sold out |
| RiverPark Advisors, LLC | 0 | $0 | 0.00% | −1,829−100.0% | Sold out |
| Harbor Investment Advisory, LLC | 0 | $0 | 0.00% | −1,502−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −227−100.0% | Sold out |
| MCF Advisors LLC | 0 | $0 | 0.00% | −187−100.0% | Sold out |
| Clear Street Markets LLC | 0 | $0 | 0.00% | −84−100.0% | Sold out |
| Huntington National Bank | 0 | $0 | 0.00% | −81−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −56−100.0% | Sold out |
| Amundi | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Smartleaf Asset Management LLC | 0 | $0 | 0.00% | −17−100.0% | Sold out |
| Coldstream Capital Management Inc | 0 | $0 | 0.00% | −16−100.0% | Sold out |
| Stephens Consulting, LLC | 0 | $0 | 0.00% | −15−100.0% | Sold out |
| Whipplewood Advisors, LLC | 0 | $0 | 0.00% | −179−100.0% | Sold out |
| Bell Investment Advisors, Inc | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| Skopos Labs, Inc. | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Farther Finance Advisors, LLC | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Credit Agricole S A | – | – | – | – | Not filed |
| CAPROCK Group, Inc. | – | – | – | – | Not filed |
| Grant/GrossMendelsohn, LLC | – | – | – | – | Not filed |
| Lindbrook Capital, LLC | – | – | – | – | Not filed |